CDC Approves Novavax Covid-19 Vaccine


The US Centers for Disease Control and Prevention (CDC) has approved the recommendation of the agency’s vaccine advisors “to use the Novavax Covid-19 vaccine as a two-dose primary series in adults”.

In a news release, the CDC writes “Novavax’s COVID-19 vaccine, which will be available in the coming weeks, is an important tool in the pandemic and provides a more familiar type of COVID-19 vaccine technology for adults. Having multiple types of vaccines offers more options and flexibility for the public, jurisdictions, and vaccine providers.”

Quoting a statement from the President Biden, CNN writes that the President applauded the move and said ““another step forward in our nation’s fight against the virus.”

“The science and data are clear: vaccines continue to protect people from serious illness, hospitalizations, and death – and with BA.5 increasing infections, it is essential that people get themselves and their kids vaccinated and stay up to date on their COVID-19 vaccinations,” Pres. Biden added.

Describing the Novavax’s vaccine, CNN writes it is “made using small laboratory-built pieces of the coronavirus to stimulate immunity. Overall, the vaccine relies on recombinant nanoparticle technology and Novavax’s adjuvant, called Matrix-M, to stimulate an immune response and high levels of neutralizing antibodies. This protein-based approach is a more traditional one for vaccine development than the mRNA vaccines from Pfizer/BioNTech and Moderna.”

The director of the CDC, Dr Rochelle Walensky reportedly said in a statement ““If you have been waiting for a COVID-19 vaccine built on a different technology than those previously available, now is the time. to join the millions of Americans who have been vaccinated. With COVID-19 cases on the rise again across parts of the country, vaccination is critical to help protect against the complications of severe COVID-19 disease.”